| 标题 |
Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Chong-Rui Xu; Yan Zhang; Guinan Lin; Haiyong Wang; Qiming Wang; et al 出版日期:2026-10-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)